AccuSpan™ Zika Linearity Panel Spans the Dynamic Range of Assays
and Allows Evaluation of Analytical Sensitivity
In response to the Zika virus outbreak, several PCR-based assays have been developed and approved under the Emergency Use Authorization (EUA). Clinical laboratories as well as test developers need to evaluate assays across the entire reportable range for sensitivity and linearity.
Download this poster to see how we recently developed the non-infectious, full-process AccuSpan™ Zika Linearity Panel to meet this need.
Fill out the form to download this scientific poster.
Complete this form for your free download: